Stockreport

NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams

NervGen Pharma Corp. - Common stock  (NGEN) 
PDF VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharm [Read more]